Authorities rule out relationship between vaccine and cardiac arrest in Brazilian girl

Sao Paulo, Jan 20 (EFE) .- The health authorities of the Brazilian state of Sao Paulo ruled out this Thursday the relationship between the anticovid vaccine and the cardiac arrest suffered by a minor under 10 years of age 12 hours after receiving the immunizer and which led to the suspension of childhood vaccination in an entire city. “It was concluded that it is not an adverse event to the vaccine. There is no relationship with the immunizer administered. What was discovered, unfortunately, was a heart problem (of the minor) of which the parents were not aware” , declared the Secretary of Health of São Paulo, Jean Gorinchteyn, at a press conference. “From the moment we were officially informed of the occurrence, which was a cardiorespiratory arrest in a female minor 12 hours after being vaccinated, we immediately set up a technical-scientific committee of 10 specialists to assess what put the patient at risk. to that girl,” Gorinchteyn detailed. As a result of the case, the city of Lençois Paulista, with 70,000 inhabitants and located in the interior of the state, suspended for 7 days the vaccination of children between 5 and 11 years old, which was authorized in the country since last Friday. According to the secretary, who is an infectious disease doctor, with the conclusion reached in the case, it is expected that vaccination will be resumed in that municipality so that all children “return to protected classes.” The minor received the first pediatric dose of the vaccine from the US-German consortium Pfizer/BioNTech on Wednesday, until the day before the only one authorized for children between 5 and 11 years old. In a note, Pfizer stated that “there are no serious safety alerts related to the immunizer” and clinical trials with 2,268 children conducted in the United States, Finland, Poland and Spain “presented robust responses in the production of antibodies and a favorable safety profile “. This Thursday, the National Health Surveillance Agency (Anvisa, regulator) authorized the application in children between 6 and 11 years of age of the Coronavac vaccine, from the Chinese laboratory Sinovac and produced in Brazil by the Butantan Institute, attached to the Government of Sao Paulo. At the press conference, which was preceded by the vaccination of 100 children from a public school in Sao Paulo, the first of that age to receive the Coronavac, the governor, Joao Doria, indicated that with the stocks that the child population has (4.3 million) in the state will receive the first dose in the next 3 weeks. Already 5-year-old children, who were not authorized to receive the Coronavac, will be vaccinated with the Pfizer immunizer. In the event that the Ministry of Health, as the federal government has implied, does not acquire the Coronavac doses, Doria offered the immunizer for the states that require it. Different from the Pfizer vaccine, which has a pediatric version, the Coronavac used in minors is the same as in adults because it is an immunizer “with an adequate safety profile with the inactivated virus,” said the director of the Butantan Institute and hematologist Dimas Covas. These days Brazil is facing the highest peaks in infections during the pandemic but without a spike in deaths, which is attributed to the advancement of vaccination —almost 70% of its population with the full cycle of doses—. The country has almost 23.5 million confirmed cases and is approaching 622,000 deaths. EFE wgm/ag/lll

Leave a Comment